idrapril has been researched along with Hypertension in 3 studies
*Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coppini, A; Criscuoli, M; Duranti, P; Favilla, S; Ghiadoni, L; Mattei, P; Romagnoli, A; Sudano, I; Taddei, S; Virdis, A | 1 |
| Criscuoli, M; Gervasi, PG; Lippi, A; Moretti, A; Subissi, A | 1 |
| Criscuoli, M; Giachetti, A; Guelfi, M; Sardelli, G; Subissi, A | 1 |
1 trial(s) available for idrapril and Hypertension
| Article | Year |
|---|---|
Humoral and haemodynamic effects of idrapril calcium, the prototype of a new class of ACE-inhibitors, in essential hypertensive patients.
Topics: Absorption; Administration, Oral; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Cyclohexanecarboxylic Acids; Double-Blind Method; Female; Heart Rate; Hemodynamics; Humans; Hydroxylamines; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A | 1995 |
2 other study(ies) available for idrapril and Hypertension
| Article | Year |
|---|---|
Alteration of cytochrome P-450 isozymes by captopril and idrapril in hepatic and renal microsomes of normotensive and spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Blotting, Western; Captopril; Cyclohexanecarboxylic Acids; Cytochrome P-450 Enzyme System; Hydroxylamines; Hypertension; Isoenzymes; Kidney; Male; Microsomes; Microsomes, Liver; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Testosterone | 1997 |
Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bronchoconstriction; Capsaicin; Captopril; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Hydroxylamines; Hypertension; In Vitro Techniques; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Substance P | 1992 |